Evaluation of the Community Pharmacy Comorbidities Screening Service on Patients with Chronic Diseases

References

• Hasan SS, Thiruchelvam K, Kairuz T, Abbas N,Babar ZUD. Pharmacy practice and its research: evolution and definitions. In: Babar ZUD, editor. Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Elsevier - Academic Press: 2019:1–6.
   Google Scholar
• Allemann S, Foppe van Mil JW, Botermann L, Berger K, Griese N, Hersberger K. Pharmaceutical care – the PCNE definition 2013. Int J Clin Pharm. 2014;36:544–555. doi:10.1007/s11096-014-9933-x
   PubMed Web of Science ®Google Scholar
• Aslani P, Ahmed R, Alves da Costa F. The Role of Adherence in Pharmaceutical Care. The Pharmacist Guide to Implementing Pharmaceutical Care. Cham: Springer; 2019:41–57.
   Google Scholar
• Roque Obreli-Neto P, Molino Guidoni C, Oliveira Baldoni A, et al. Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm. 2011;33:642–649. doi:10.1007/s11096-011-9518-x
   Web of Science ®Google Scholar
• Wei L, Yang X, Jie L, et al. Effect of pharmaceutical care on medication adherence and hospital admission in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled study. J Thorac Dis. 2014;6:656. doi:10.3978/j.issn.2072-1439.2014.06.20
   PubMed Web of Science ®Google Scholar
• Merks P. Opieka Farmaceutyczna Od Zdefiniowania Pojęcia Do Mechanizmów Realizacji Na Przykładzie Wielkiej Brytanii. Związek Zawodowy Pracowników Farmacji (ZZPF); 2018:119.
   Google Scholar
• GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391:2236–2271.
   PubMed Web of Science ®Google Scholar
• Brown L, Seoane-Vazquez E. The Pharmacist Guide to Implementing Pharmaceutical Care. North America: Pharmaceutical Care; 2019:145–158.
   Google Scholar
• Alves da Costa F. The Pharmacist Guide to Implementing Pharmaceutical Care. Europe: Pharmaceutical Care; 2019:159–171.
   Google Scholar
• Barry HE, Hughes CM. Economical, Clinical, and Humanistic Outcomes and Pharmaceutical Care. The Pharmacist Guide to Implementing Pharmaceutical Care. Cham: Springer; 2019:119–127.
   Google Scholar
• Świeczkowski D, Bandurska E, Merks P, Krysiński J. Opieka farmaceutyczna w szpitalu szansą na poprawienie ekonomii szpitala, zdrowia pacjenta i budżetu państwa [Pharmaceutical care in a hospital as an opportunity to improve the hospital’s economy, patient health and the state budget]. Farm Pol. 2013;69:567–570.
   Google Scholar
• Wrigh D, Little R, Turner D, Thornley T. Diabetes screening through community pharmacies in England: a cost-effectiveness study. Pharmacy. 2019;7:1–12.
   Web of Science ®Google Scholar
• Rynek apteczny w sierpniu 2019 wyżej niż rok wcześniej (+2.3%). Spadek względem lipca 2019 (−6.7%); 2019. Available from: http://www.aptekarzpolski.pl/2019/09/rynek-apteczny-w-sierpniu-2019-wyzej-niz-rok-wczesniej-2-3-spadek-wzgledem-lipca-2019-6-7/. Accessed August 13, 2020.
   Google Scholar
• Corlett SA, Krska J. Evaluation of NHS health checks provided by community pharmacies. J Public Health (Oxf). 2016;38(4):e516–e523. doi:10.1093/pubmed/fdv153
   Web of Science ®Google Scholar
• Mc Namara KP, Krass I, Peterson GM, et al. Implementing screening interventions in community pharmacy to promote interprofessional coordination of primary care - a mixed methods evaluation. Res Social Adm Pharm. 2020;16(2):160–167. doi:10.1016/j.sapharm.2019.04.011
   Web of Science ®Google Scholar
• NHF on health. Registered Epidemiology. Warsaw, Warszawa: Cukrzyca, Headquarters of the National Health Fund; 2019:12–17.
   Google Scholar
• NHF on health. Hypertension in the Data of the National Health Fund, Hypertension. Warsaw: National Health Fund Headquarters; 2019:13–32.
   Google Scholar
• Scaratti C, Leonardi M, Silvaggi F, et al. Mapping European Welfare Models: state of the art of strategies for professional integration and reintegration of persons with chronic diseases. Int J Environ Res Public Health. 2018;15(4):781–801. doi:10.3390/ijerph15040781
   Web of Science ®Google Scholar
• Health at a glance: Europe 2016 State of health in the EU cycle; 2016. Available from: https://www.oecd-ilibrary.org/docserver/9789264265592en.pdf?expires=1590314324&id=id&accname=guest&checksum=648349C2A614F180B8422DA0D4BC7FF2. Accessed January 27, 2021.
   Google Scholar
• Brennan P, Perola M, van Ommen GJ, Riboli E; European Cohort Consortium. Chronic disease research in Europe and the need for integrated population cohorts. Eur J Epidemiol. 2017;32(9):741–749. doi:10.1007/s10654-017-0315-2
   PubMed Web of Science ®Google Scholar
• NFZ o zdrowiu, nadciśnienie tętnicze [NHF on health, arterial hypertension]; 2019. Available from: https://zdrowedane.nfz.gov.pl/pluginfile.php/80/mod_resource/content/1/nadcisnienie-tetnicze-raport-nfz-2019-small.pdf. Accessed August 24, 2020.
   Google Scholar
• NFZ o zdrowiu, cukrzyca [NHF on health, diabetes]; 2019. Available from: https://zdrowedane.nfz.gov.pl/pluginfile.php/205/mod_resource/content/4/nfz_o_zdrowiu_cukrzyca.pdf. Accessed August 24, 2020.
   Google Scholar
• Krass I, Hoti K, Mc Namara K. Management of endocrine disorders and the Pharmacist’s role: diabetes. In: Zaheer-Ud-Din B, editor. Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Elsevier Inc; 2019:447–460.
   Google Scholar
• Goto M, Goto A, Ikeda N, Noda H, Shibuya K, Noda M. Factors associated with untreated diabetes: analysis of data from 20,496 participants in the Japanese National Health and Nutrition Survey. PLoS One. 2015;10(3):1–8. doi:10.1371/journal.pone.0118749
   Web of Science ®Google Scholar
• Ismail H, Azahadi Omar M, Aqilah Noor Hisham A, et al. Undiagnosed type 2 diabetes mellitus and its risk factors among malaysians: findings of a nationwide study. Int J Public Health Res. 2016;6:677–684.
   Google Scholar
• Clarke P, Gray A, Legood R, Briggs A, Holman R. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med. 2003;20(6):442–450. doi:10.1046/j.1464-5491.2003.00972.x
   PubMed Web of Science ®Google Scholar
• Deyo D, Hemingway J, Hughes DR. Identifying patients with undiagnosed chronic conditions: an examination of patient costs before chronic disease diagnosis. J Am Coll Radiol. 2015;12(12):1388–1394. doi:10.1016/j.jacr.2015.09.012
   Web of Science ®Google Scholar
• Benefits and risks of screening tests; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279418/. Accessed September 24, 2020.
   Google Scholar
• Fórmankiewicz B, Jawień A. The role of screening in early diagnosis of abdominal aortic aneurysm. Acta Angiol. 2012;18:1–8.
   Google Scholar
• What makes a screening exam “good”?; 2006. Available from: https://journalofethics.ama-assn.org/article/what-makes-screening-exam-good/2006-01. Accessed September 30, 2020.
   Google Scholar
• Ayorinde AA, Porteous T, Sharma P. Screening for major diseases in community pharmacies: a systematic review. Int J Pharm Pract. 2013;21(6):349–361. doi:10.1111/ijpp.12041
   Google Scholar
• Hohmeier KC, Loomis B, Gatwood J. Consumer perceptions of and willingness-to-pay for point-of-care testing services in the community pharmacy. Res Social Adm Pharm. 2018;14(4):360–366. doi:10.1016/j.sapharm.2017.04.011
   Web of Science ®Google Scholar
• Brewer A, Hanna C, Eckmann L, Schadler A, Divine H. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy. J Am Pharm Assoc (2003). 2018;58(4):69–72. doi:10.1016/j.japh.2018.04.031
   Web of Science ®Google Scholar
• Service specification for NHS community pharmacy blood pressure and atrial fibrillation drop-in service; 2018. Available from: https://psnc.org.uk/nottinghamshire-lpc/wp-content/uploads/sites/21/2019/02/2018_01_DENO-Blood-Pressure-and-AF-ScreeningProject-Service-Specificati….pdf. Accessed September 28, 2020.
   Google Scholar
• Hill H, Cardosi L, Henson L, et al. Evaluating advanced pharmacy technician roles in the provision of point-of-care testing. J Am Pharm Assoc (2003). 2020;60(4):1–6. doi:10.1016/j.japh.2020.02.024
   Web of Science ®Google Scholar
• Merks P. Informacje dla aptek i farmaceutów: usługa farmaceutyczna skieruj pacjenta - do laboratorium na badanie profilaktyczne [Information for pharmacies and pharmacists: pharmaceutical service refer the patient - to the laboratory for a preventive examination]; 2019. Available from: https://www.skierujpacjenta.pl/o-projekcie. Accessed September 28, 2020.
   Google Scholar
• Programy pilotażowe opieki farmaceutycznej w Polsce [Pilot pharmaceutical care programs in Poland]; 2019. Available from: https://www.nia.org.pl/2019/03/14/programy-pilotazowe-opieki-farmaceutycznej-w-polsce/. Accessed September 28, 2020.
   Google Scholar
• Skieruj pacjenta [refer the patient]; 2019. Available from: https://www.facebook.com/Skieruj-Pacjenta-489016134955707/. Accessed September 28, 2020.
   Google Scholar
• NIA on Pharmaceutical Care Pilot Programs. NIA o programach pilotażowych opieki farmaceutycznej; 2019. Available from: https://www.aptekarzpolski.pl/aktualnosci/nia-o-programach-pilotazowych-opieki-farmaceutycznej/. Accessed September 28, 2020.
   Google Scholar
• Skieruj pacjenta! [refer the patient!]; 2019. Available from: http://www.farmakoekonomika.com.pl/skieruj-pacjenta/. Accessed September 28, 2020.
   Google Scholar
• Europejski program badania pilotażowego usług opieki farmaceutycznej w chorobach przewlekłych [European Chronic Disease Pharmaceutical Care Pilot Study Program]; 2019. Available from: https://www.loia.pl/news/2418/europejski-program-badania-pilotazowego-uslug-opieki.html. Accessed September 28, 2020.
   Google Scholar
• Usługa farmaceutyczna: skieruj pacjenta [pharmaceutical service: refer the patient]; 2019. Available from: https://www.youtube.com/watch?v=74VdWns-1fM. Accessed September 28, 2020.
   Google Scholar
• Busse R, Blümel M, Scheller-Kreinsen D, Zentner A. Tackling Chronic Disease in Europe - Strategies, Interventions and Challenges. European Observatory on Health Systems and Policies. WHO Regional Office Europe; 2010:111.
   Google Scholar
• Saldarriaga EM, Vodicka E, La Rosa S, Valderrama M, Garcia PJ. Point-of-care testing for anemia, diabetes, and hypertension: a pharmacy-based model in Lima, Peru. Ann Glob Health. 2017;83(2):394–404. doi:10.1016/j.aogh.2017.03.514
   Web of Science ®Google Scholar
• Sushilkumar PL, Mahendrakumar BJ, Suman B, Gloria S, Chaitanya K. Implementation and evaluation of health screening services to diabetic and hypertensive patients in a selected community pharmacy at belgaum city. Asian J Pharm Clin Res. 2015;8:305–315.
   Google Scholar
• Jahangard-Rafsanjani Z, Hakimzadeh N, Sarayani A, et al. A community pharmacy-based cardiovascular risk screening service implemented in Iran. Pharm Pract (Granada). 2017;15(2):1–6. doi:10.18549/PharmPract.2017.02.919
   Web of Science ®Google Scholar
• Waszyk-Nowaczyk M, Guzenda W, Plewka B, et al. Screening services in a community pharmacy in Poznan (Poland) to increase early detection of hypertension. J Clin Med. 2020;9(8):2572–2583. doi:10.3390/jcm9082572
   PubMed Web of Science ®Google Scholar
• Gruman J, Rovner MH, French ME, et al. From patient education to patient engagement: implications for the field of patient education. Patient Educ Couns. 2010;78(3):350–356. doi:10.1016/j.pec.2010.02.002
   PubMed Web of Science ®Google Scholar
• Gnavi R, Sciannameo V, Baratta F, et al. Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy. PLoS One. 2020;15(3):1–11. doi:10.1371/journal.pone.0229842
   Web of Science ®Google Scholar
• Aptekarz Polski, Opieka farmaceutyczna – w opinii aptekarzy [Polish pharmacist, pharmaceutical care - in the opinion of pharmacists]; 2010. Available from: https://www.aptekarzpolski.pl/opieka-farmaceutyczna/01-2010-opieka-farmaceutyczna-w-opinii-aptekarzy/. Accessed October 8, 2020.
   Google Scholar
• Briesacher B, Corey R. Patient satisfaction with pharmaceutical services at independent and chain pharmacies. Am J Health Syst Pharm. 1997;54(5):531–536. doi:10.1093/ajhp/54.5.531
   PubMed Web of Science ®Google Scholar
• Główny Urząd Statystyczny, Apteki i punkty apteczne w 2018 roku [Central Statistical Office of Poland, pharmacies and pharmacy outlets in 2018]; 2018. Available from: https://stat.gov.pl/obszary-tematyczne/zdrowie/zdrowie/apteki-i-punkty-apteczne-w-2018-roku,15,3.html. Accessed October 5, 2020.
   Google Scholar
• Merks P, Bryła A, Harężlak T, et al. Ocena jakości pracy farmaceutów w aptekach ogólnodostępnych na terenie Polski [Assessment of the quality of pharmacists’ work in generally accessible pharmacies in Poland]. Farm Pol. 2019;75:233–237. doi:10.32383/farmpol/116222
   Google Scholar
• World Health Organization. Density of pharmacists (total number per 10 000 population, latest available year); 2018. Available from: https://www.who.int/gho/health_workforce/pharmacists_density/en/. Accessed September 18, 2020.
   Google Scholar
• Willis A, Rivers P, Gray LJ, Davies M, Khunti K. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS One. 2014;9(4):1–9. doi:10.1371/journal.pone.0091157
   Web of Science ®Google Scholar
• Fikri-Benbrahim N, Martínez-Martínez F, Saéz-Benito L, et al. Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow study. Diabetes Res Clin Pract. 2015;108(3):49–52. doi:10.1016/j.diabres.2015.03.006
   Web of Science ®Google Scholar
• Wawryniuk A, Rybak M, Szwajkosz K, et al. Choroba Leśniowskiego Crohna będąca przewlekłym stanem zapalnym przewodu pokarmowego [Crohn’s disease, which is a chronic inflammation of the gastrointestinal tract]. J Educ. 2017;7:80–98.
   Google Scholar
• Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from project ImPACT: osteoporosis. J Am Pharm Assoc (2003). 2004;44(2):152–160. doi:10.1331/154434504773062609
   Google Scholar
• Athar MW, Mativo C, Landis R, Wright SM. Communication of laboratory data and diagnostic test results to hospitalized patients: a study of preferences and recall. Patient Prefer Adherence. 2016;10:1409–1413. doi:10.2147/PPA.S111190
   Web of Science ®Google Scholar
• Dhippayom T, Fuangchan A, Tunpichart S, Chaiyakunapruk N. Opportunistic screening and health promotion for type 2 diabetes: an expanding public health role for the community pharmacist. J Public Health (Oxf). 2013;35(2):262–269. doi:10.1093/pubmed/fds078
   Web of Science ®Google Scholar
• Merks P, Świeczkowski D, Blicharska E, et al. Perspektywy wdrożenia opieki farmaceutycznej do praktyki aptecznej w warunkach polskiego systemu opieki zdrowotnej [Prospects for the implementation of pharmaceutical care into pharmacy practice in the conditions of the Polish healthcare system]. Czasopismo Aptekarskie. 2015;8–9:28–38.
   Google Scholar
• Lavelle J, Schast A, Keren R. Standardizing care processes and improving quality using pathways and continuous quality improvement. Curr Treat Options Peds. 2015;1:347–358. doi:10.1007/s40746-015-0026-4
   Google Scholar